Dissertation Defence: Deepankar Chakroborty
Comprehensive genetic characterization of cancer tissues was enabled with the advent of next-generation sequencing technologies. These methods helped scientists peer into the cancer genomes, and in the process, improved our understanding about the molecular players and the driver events in the life cycle of several human cancers. In addition to generating a small list of driver mutations, the large-scale sequencing efforts generated a long “tail” consisting of “variants of unknown significance” (VUS), which are cancer-associated somatic mutations with uncharacterized functional significance.
Identification of driver mutations is an integral part of biomarker discovery in cancer research, and this thesis aimed to address this by developing a screening platform called, in vitro screen for activating mutations (iSCREAM), and a Database of Recurrent Mutations (DORM). iSCREAM is a high-throughput screen for identification of gain-of-function mutations in oncogenic kinases. The workflow was used to study EGFR and ERBB4 and identified activating mutations which were previously reported to be VUS. DORM was prepared by analyzing a public registry of somatic mutations and preparing a catalog of the mutations identified from genome-wide studies to recapitulate the “real-world” frequency of all the recurrent (n > 1) somatic mutations. DORM allows limiting the scope of search to 38 tissue types and supports advanced queries using regular expressions. The easy-to-use database and its backend are written to be very responsive and fast in comparison to contemporary public cancer databases.
MSc Deepankar Chakroborty will present his thesis on Thursday, February 9.
Opponent: Professor René Bernards (The Netherlands Cancer Institute, Amsterdam, Netherlands)
Custos: Professor Klaus Elenius (Faculty of Medicine, University of Turku, Finland)
Date and Time: February 9, 2023 at 14.15 PM
Place: Mauno Presidentti Auditorium, Biocity, Tykistökatu 6, Turku, FI-20520.
Link to thesis: https://urn.fi/URN:ISBN:978-951-29-9098-6
Recent Posts
- New computational tool helps scientists interpret complex single-cell data Researchers from Laura Elo’s group, have developed a new computational method to interpret complex single-cell Read moreNovember 17, 2025
- Carlos Rogério Figueiredo received the Young Investigator Award Carlos Rogério Figueiredo has received the Young Investigator Award from the Scandinavian Society for Immunology. Read moreNovember 4, 2025
- Participate to Open Hardware Workshop, sign up now! Access to research hardware remains a global challenge and it impacts also researchers in high-income Read moreNovember 3, 2025
- The Academy of Finland granted Johanna Ivaska €2,400,000 in funding for an Academy Professor position The Academy of Finland granted our Group Leader, Professor Johanna Ivaska €2,400,000 in funding for Read moreOctober 30, 2025
- Guillaume Jacquemet and Cecilia Sahlgren receive funding for the Research Council of Finland Centre of Excellence in Immune-Endothelial Interactions (IMMENs) Associate Professor Guillaume Jacquemet, our Group Leader, and Professor Cecilia Sahlgren, our affiliated Group Leader, Read moreOctober 30, 2025
- Registration to AI2Med imaging event is now open! Registration for AI2Med Turku 2025 is open! The event is organized by the Turku PET Read moreOctober 21, 2025